1. Home
  2. MYNZ
  3. MYNZ News

Latest Mainz Biomed N.V. (MYNZ) News on February 23, 2025

Mainz Biomed Expands into Switzerland with labor team w
MYNZ

GlobeNewswire

3 days ago

Mainz Biomed Expands into Switzerland with labor team w

Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month
MYNZ

GlobeNewswire

12 days ago

Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month

Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements
MYNZ

GlobeNewswire

a month ago

Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements

Mainz Biomed Initiates U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over Large Patient Population
MYNZ

GlobeNewswire

a month ago

Mainz Biomed Initiates U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over Large Patient Population

Mainz Biomed partners with Quest for colorectal cancer screening test
MYNZ

Medical Device Network

2 months ago

Mainz Biomed partners with Quest for colorectal cancer screening test

MYNZ

MT Newswires

2 months ago

Mainz Biomed Partners With Quest Diagnostics for Colorectal Cancer Screening Test

Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test
MYNZ

GlobeNewswire

2 months ago

Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test

Mainz Biomed Announces Closing of $8.0 Million Follow-On Offering
MYNZ

GlobeNewswire

2 months ago

Mainz Biomed Announces Closing of $8.0 Million Follow-On Offering

Mainz Biomed Announces Pricing of $8.0 Million Follow-On Offering Priced at-the-Market Under Nasdaq Rules
MYNZ

GlobeNewswire

2 months ago

Mainz Biomed Announces Pricing of $8.0 Million Follow-On Offering Priced at-the-Market Under Nasdaq Rules

MYNZ

MT Newswires

3 months ago

Mainz Biomed to Implement 1-for-40 Reverse Stock Split

Mainz Biomed Announces Stock Split
MYNZ

GlobeNewswire

3 months ago

Mainz Biomed Announces Stock Split

The Oncology Bet Is Already Paying Off For Pfizer
MYNZ

Benzinga

3 months ago

The Oncology Bet Is Already Paying Off For Pfizer

MYNZ

MT Newswires

3 months ago

Mainz Biomed, Thermo Fisher Partner to Develop Colorectal Cancer Screening Test

Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets
MYNZ

GlobeNewswire

3 months ago

Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets

Mainz Biomed restructured operations, implemented cost reductions
MYNZ

TipRanks

4 months ago

Mainz Biomed restructured operations, implemented cost reductions

Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update
MYNZ

GlobeNewswire

4 months ago

Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update

Mainz Biomed Secures Additional $1.5M Funding
MYNZ

TipRanks

4 months ago

Mainz Biomed Secures Additional $1.5M Funding

Mainz Biomed Reports Increased Demand for Enhanced ColoAlert, Existing Partners to Transition to New Version
MYNZ

GlobeNewswire

5 months ago

Mainz Biomed Reports Increased Demand for Enhanced ColoAlert, Existing Partners to Transition to New Version

The Covid Era Tech Promises To Reinvent Cancer Treatment
MYNZ

Benzinga

5 months ago

The Covid Era Tech Promises To Reinvent Cancer Treatment

Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025
MYNZ

GlobeNewswire

5 months ago

Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025

Pfizer Advances On Its Cancer Journey
MYNZ

Benzinga

5 months ago

Pfizer Advances On Its Cancer Journey

Mainz Biomed Announces Petra Smeltzer Starke to Join Company as Brand Ambassador
MYNZ

GlobeNewswire

5 months ago

Mainz Biomed Announces Petra Smeltzer Starke to Join Company as Brand Ambassador

MYNZ

MT Newswires

6 months ago

Mainz Biomed Expands AI Collaboration With Liquid Biosciences to Include Pancreatic Cancer Test

Mainz Biomed Partners with Liquid Biosciences to Leverage the Power of Artificial Intelligence for the Expansion and Optimization of Biomarker Selection for PancAlert
MYNZ

GlobeNewswire

6 months ago

Mainz Biomed Partners with Liquid Biosciences to Leverage the Power of Artificial Intelligence for the Expansion and Optimization of Biomarker Selection for PancAlert

Pfizer Records First Sales Growth In Its Post-Covid Era And It Owes It To Cancer
MYNZ

Benzinga

7 months ago

Pfizer Records First Sales Growth In Its Post-Covid Era And It Owes It To Cancer

Mainz Biomed Launches Enhanced ColoAlert with Cutting-Edge Features to Optimize Screening Efficiency and User Convenience
MYNZ

GlobeNewswire

7 months ago

Mainz Biomed Launches Enhanced ColoAlert with Cutting-Edge Features to Optimize Screening Efficiency and User Convenience

Mainz Biomed seeks FDA breakthrough device status for colorectal cancer test
MYNZ

Medical Device Network

7 months ago

Mainz Biomed seeks FDA breakthrough device status for colorectal cancer test

MYNZ

MT Newswires

7 months ago

Top Premarket Gainers

Mainz Biomed Announces Submission for FDA Breakthrough Device Designation for its Next Generation CRC Screening Test
MYNZ

GlobeNewswire

7 months ago

Mainz Biomed Announces Submission for FDA Breakthrough Device Designation for its Next Generation CRC Screening Test

mRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment
MYNZ

Benzinga

8 months ago

mRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment

Mainz Biomed Provides Half Year 2024 Corporate Update
MYNZ

GlobeNewswire

8 months ago

Mainz Biomed Provides Half Year 2024 Corporate Update

Catherine Wood's Strategic Acquisition of PagerDuty Inc Shares
MYNZ

GuruFocus.com

8 months ago

Catherine Wood's Strategic Acquisition of PagerDuty Inc Shares

ADM Animal Nutrition Expands Recall to Include Additional Lots of Various Feed Products
MYNZ

Business Wire

8 months ago

ADM Animal Nutrition Expands Recall to Include Additional Lots of Various Feed Products

Insider Sale at Cogent Communications Holdings Inc (CCOI): CFO Thaddeus Weed Sells 2,400 Shares
MYNZ

GuruFocus.com

8 months ago

Insider Sale at Cogent Communications Holdings Inc (CCOI): CFO Thaddeus Weed Sells 2,400 Shares

Factbox-Here's everything Apple announced at WWDC
MYNZ

Reuters

8 months ago

Factbox-Here's everything Apple announced at WWDC

Elon Musk's Tesla pay package: More shareholders speak out
MYNZ

Yahoo Finance Video

8 months ago

Elon Musk's Tesla pay package: More shareholders speak out

Cargojet enters charter deal for Chinese e-commerce
MYNZ

FreightWaves

8 months ago

Cargojet enters charter deal for Chinese e-commerce

AVENUE 8 DOUBLES DOWN ON GENERATIVE AI, SHIFTS FOCUS TO SIDEKICK PLATFORM FOR REAL ESTATE AGENTS
MYNZ

PR Newswire

8 months ago

AVENUE 8 DOUBLES DOWN ON GENERATIVE AI, SHIFTS FOCUS TO SIDEKICK PLATFORM FOR REAL ESTATE AGENTS

Enghouse Releases Second Quarter Results
MYNZ

CNW Group

8 months ago

Enghouse Releases Second Quarter Results

Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
MYNZ

Benzinga

9 months ago

Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon

Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
MYNZ

GlobeNewswire

9 months ago

Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024

Mainz Biomed Reports Results of 2024 Annual General Meeting
MYNZ

GlobeNewswire

9 months ago

Mainz Biomed Reports Results of 2024 Annual General Meeting

Mainz Biomed to Present New Pooled Colorectal Cancer Screening Data, its Largest Study to Date, at ASCO 2024 Annual Meeting
MYNZ

GlobeNewswire

9 months ago

Mainz Biomed to Present New Pooled Colorectal Cancer Screening Data, its Largest Study to Date, at ASCO 2024 Annual Meeting

Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for its Planned FDA Trial
MYNZ

GlobeNewswire

9 months ago

Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for its Planned FDA Trial

Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
MYNZ

Benzinga

9 months ago

Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game

Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.
MYNZ

GlobeNewswire

10 months ago

Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.

mRNA Is Promising A Breakthrough In Fighting Cancer
MYNZ

Benzinga

10 months ago

mRNA Is Promising A Breakthrough In Fighting Cancer

Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic
MYNZ

GlobeNewswire

10 months ago

Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic

The Pharmaceutical Industry Finds Itself At A Historical Crossroads
MYNZ

Benzinga

10 months ago

The Pharmaceutical Industry Finds Itself At A Historical Crossroads

Mainz Biomed Reports Full Year 2023 Financial Results
MYNZ

GlobeNewswire

10 months ago

Mainz Biomed Reports Full Year 2023 Financial Results

Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment
MYNZ

GlobeNewswire

a year ago

Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatment

Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options
MYNZ

GlobeNewswire

a year ago

Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Options

Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations
MYNZ

GlobeNewswire

a year ago

Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations

What Makes Mainz Biomed NV (MYNZ) a New Buy Stock
MYNZ

Zacks

a year ago

What Makes Mainz Biomed NV (MYNZ) a New Buy Stock

Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic
MYNZ

GlobeNewswire

a year ago

Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnostic

Gynecology Plays A Pivotal Role In Colorectal and Endometrial Cancer Screening
MYNZ

Benzinga

a year ago

Gynecology Plays A Pivotal Role In Colorectal and Endometrial Cancer Screening

Mainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical Community
MYNZ

GlobeNewswire

a year ago

Mainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical Community

Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment
MYNZ

Benzinga

a year ago

Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment

Mainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert®
MYNZ

GlobeNewswire

a year ago

Mainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert®

Mainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in Italy
MYNZ

GlobeNewswire

a year ago

Mainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in Italy

2024 Promises To Bring Pharmaceutical Breakthroughs On The Oncology Front
MYNZ

Benzinga

a year ago

2024 Promises To Bring Pharmaceutical Breakthroughs On The Oncology Front

Mainz Biomed Establishes Physician-Led Laboratory Expanding Service Offering for Privately Insured Patients in Germany
MYNZ

GlobeNewswire

a year ago

Mainz Biomed Establishes Physician-Led Laboratory Expanding Service Offering for Privately Insured Patients in Germany

Pfizer Surprises With Profit But Revolutionizing Cancer Treatment Is Its Best Chance Of Getting Back In The Saddle
MYNZ

Benzinga

a year ago

Pfizer Surprises With Profit But Revolutionizing Cancer Treatment Is Its Best Chance Of Getting Back In The Saddle

AVROBIO and Tectonic Therapeutic Announce Merger
MYNZ

Business Wire

a year ago

AVROBIO and Tectonic Therapeutic Announce Merger

MAGYAR BANCORP, INC. ANNOUNCES FIRST QUARTER FINANCIAL RESULTS AND DECLARES DIVIDEND
MYNZ

PR Newswire

a year ago

MAGYAR BANCORP, INC. ANNOUNCES FIRST QUARTER FINANCIAL RESULTS AND DECLARES DIVIDEND

Chuck Royce Increases Stake in Express, Inc.
MYNZ

GuruFocus.com

a year ago

Chuck Royce Increases Stake in Express, Inc.

CORRECTION – Oak Valley Bancorp Reports 4th Quarter Results and Announces Cash Dividend
MYNZ

GlobeNewswire

a year ago

CORRECTION – Oak Valley Bancorp Reports 4th Quarter Results and Announces Cash Dividend

D-Wave Names Kirstjen Nielsen, Former Secretary of Homeland Security, to Board of Directors
MYNZ

Business Wire

a year ago

D-Wave Names Kirstjen Nielsen, Former Secretary of Homeland Security, to Board of Directors

Idaho Strategic to Participate in Upcoming Industry Events
MYNZ

ACCESSWIRE

a year ago

Idaho Strategic to Participate in Upcoming Industry Events

Allakos Announces Phase 2 Lirentelimab Trials in Atopic Dermatitis and Chronic Spontaneous Urticaria Did Not Meet Their Primary Endpoints
MYNZ

GlobeNewswire

a year ago

Allakos Announces Phase 2 Lirentelimab Trials in Atopic Dermatitis and Chronic Spontaneous Urticaria Did Not Meet Their Primary Endpoints

A Look Back at Specialty Retail Stocks' Q3 Earnings: Petco (NASDAQ:WOOF) Vs The Rest Of The Pack
MYNZ

StockStory

a year ago

A Look Back at Specialty Retail Stocks' Q3 Earnings: Petco (NASDAQ:WOOF) Vs The Rest Of The Pack

Euroseas Ltd. Announces Time Charter Contract for its Fuel-Efficient 2,800 teu Feeder Containership, M/V Tender Soul, to be delivered in February 2024
MYNZ

GlobeNewswire

a year ago

Euroseas Ltd. Announces Time Charter Contract for its Fuel-Efficient 2,800 teu Feeder Containership, M/V Tender Soul, to be delivered in February 2024

Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium
MYNZ

GlobeNewswire

a year ago

Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium

AmpliTech Group Unveils AGTGSS Flagship Product, A Massive MIMO, 64T64R ORAN, CAT B Radio And Launches New AGTGSS Division Website
MYNZ

GlobeNewswire

a year ago

AmpliTech Group Unveils AGTGSS Flagship Product, A Massive MIMO, 64T64R ORAN, CAT B Radio And Launches New AGTGSS Division Website

2024 Marks a New Era Of Pharmaceutical Innovation
MYNZ

Benzinga

a year ago

2024 Marks a New Era Of Pharmaceutical Innovation

Mainz Biomed Provides Year-End Corporate Review 2023
MYNZ

GlobeNewswire

a year ago

Mainz Biomed Provides Year-End Corporate Review 2023

Cancer Cell Therapy Focused Marker Therapeutics Announces Pipeline Prioritization
MYNZ

Benzinga

a year ago

Cancer Cell Therapy Focused Marker Therapeutics Announces Pipeline Prioritization

MYNZ

Reuters

a year ago

Cellectar's blood cancer therapy succeeds in trial

Billionaire Louis Bacon’s 15 Long-Term Stock Picks
MYNZ

Insider Monkey

a year ago

Billionaire Louis Bacon’s 15 Long-Term Stock Picks

Assertio (ASRT) Shares Fall as Dan Peisert Steps Down as CEO
MYNZ

Zacks

a year ago

Assertio (ASRT) Shares Fall as Dan Peisert Steps Down as CEO

Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference
MYNZ

PR Newswire

a year ago

Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference

Investors in Heritage Global (NASDAQ:HGBL) have seen fantastic returns of 480% over the past five years
MYNZ

Simply Wall St.

a year ago

Investors in Heritage Global (NASDAQ:HGBL) have seen fantastic returns of 480% over the past five years

2023 Will Go Down As The Year Pharma Showed Its Determination To Beat Cancer
MYNZ

Benzinga

a year ago

2023 Will Go Down As The Year Pharma Showed Its Determination To Beat Cancer

7 Nano-Cap Stocks That Pack a Serious Punch for Their Weight
MYNZ

InvestorPlace

a year ago

7 Nano-Cap Stocks That Pack a Serious Punch for Their Weight

These Stocks under $10 Are Poised To Explode
MYNZ

Insider Monkey

a year ago

These Stocks under $10 Are Poised To Explode

Are Options Traders Betting on a Big Move in Airgain (AIRG) Stock?
MYNZ

Zacks

a year ago

Are Options Traders Betting on a Big Move in Airgain (AIRG) Stock?

Mainz Biomed and Bantleon Partner to Elevate Corporate Health with Second Phase of CRC Screening Program for Employees
MYNZ

GlobeNewswire

a year ago

Mainz Biomed and Bantleon Partner to Elevate Corporate Health with Second Phase of CRC Screening Program for Employees

Sleep Number Corporation's (NASDAQ:SNBR) 48% Share Price Surge Not Quite Adding Up
MYNZ

Simply Wall St.

a year ago

Sleep Number Corporation's (NASDAQ:SNBR) 48% Share Price Surge Not Quite Adding Up

Insider Buying: Chief Medical Officer Vojo Vukovic Acquires 40,000 Shares of Delcath Systems ...
MYNZ

GuruFocus.com

a year ago

Insider Buying: Chief Medical Officer Vojo Vukovic Acquires 40,000 Shares of Delcath Systems ...

U.S. Forest Service Issues an Environmental Assessment and Draft Decision of No Significant Impact on Solitario's Proposed Golden Crest Drilling Program
MYNZ

ACCESSWIRE

a year ago

U.S. Forest Service Issues an Environmental Assessment and Draft Decision of No Significant Impact on Solitario's Proposed Golden Crest Drilling Program

Mainz Biomed Showcases ColoAlert® at Two Prominent Gastroenterology Conferences in Poland
MYNZ

GlobeNewswire

a year ago

Mainz Biomed Showcases ColoAlert® at Two Prominent Gastroenterology Conferences in Poland

Shareholders May Not Be So Generous With BioSig Technologies, Inc.'s (NASDAQ:BSGM) CEO Compensation And Here's Why
MYNZ

Simply Wall St.

a year ago

Shareholders May Not Be So Generous With BioSig Technologies, Inc.'s (NASDAQ:BSGM) CEO Compensation And Here's Why

Water Tower Research US Climate Virtual Investor Conference: Presentations Now Available for Online Viewing
MYNZ

GlobeNewswire

a year ago

Water Tower Research US Climate Virtual Investor Conference: Presentations Now Available for Online Viewing

New to The Street TV Announces Its Episode 536 Lineup, Five Corporate Guest Interviews, Broadcasted as Sponsored Program on Bloomberg TV, Tonight, Thursday, December 7, 2023, at 9:30 PM PT
MYNZ

GlobeNewswire

a year ago

New to The Street TV Announces Its Episode 536 Lineup, Five Corporate Guest Interviews, Broadcasted as Sponsored Program on Bloomberg TV, Tonight, Thursday, December 7, 2023, at 9:30 PM PT

We Think Exscientia (NASDAQ:EXAI) Needs To Drive Business Growth Carefully
MYNZ

Simply Wall St.

a year ago

We Think Exscientia (NASDAQ:EXAI) Needs To Drive Business Growth Carefully

While Pfizer Faced A Setback, Altimmune, Roche And Mainz Biomed Advanced in The Battle Against Obesity And Colorectal Cancer
MYNZ

Benzinga

a year ago

While Pfizer Faced A Setback, Altimmune, Roche And Mainz Biomed Advanced in The Battle Against Obesity And Colorectal Cancer

Investment Management Giant Selects eGain to Modernize Knowledge Management
MYNZ

GlobeNewswire

a year ago

Investment Management Giant Selects eGain to Modernize Knowledge Management

Chicago Atlantic Real Estate Finance, Inc.'s (NASDAQ:REFI) top owners are individual investors with 49% stake, while 34% is held by institutions
MYNZ

Simply Wall St.

a year ago

Chicago Atlantic Real Estate Finance, Inc.'s (NASDAQ:REFI) top owners are individual investors with 49% stake, while 34% is held by institutions

MYNZ

PR Newswire

a year ago

Royce Global Value Trust, Inc. (NYSE-RGT) declares Year-end Common Stock Distribution of $0.15 Per Share

Sol-Gel Technologies Ltd to Host Virtual KOL Event on Gorlin Syndrome and the Upcoming Phase 3 Trial for SGT-610
MYNZ

GlobeNewswire

a year ago

Sol-Gel Technologies Ltd to Host Virtual KOL Event on Gorlin Syndrome and the Upcoming Phase 3 Trial for SGT-610

Share on Social Networks: